INSTRIDE HEALTH PROVIDING VIRTUAL PEDIATRIC ANXIETY/OCD TREATMENT LAUNCHES WITH SUPPORT FROM MCLEAN HOSPITAL AND LEADING HEALTHCARE INVESTORS
Summary
This unique approach improves access and affordability while providing rapid, sustainable results that also address or prevent progression of common secondary issues such as school nonattendance, substance use, depression, and suicidality. ", part of Mass General Brigham, is a world recognized leader in psychiatric care, research, professional and community education, outreach, and advocacy and is providing a range of advisory services to further InStrides growth. Driven by the belief that children and families living with mental health struggles deserve better access and outcomes so they never have to worry alone, InStride is more than a continuum of careits a pathway to a healthier life and hope for a more promising future. The firm leads, or co-leads, first institutional investment rounds in market-changing digital health and enterprise IT companies and world-class operators, who move quickly and embody successful entrepreneurial DNA with their passion, creativity and endurance. .Valtruis, a Welsh, Carson, Anderson & Stowe company, provides a unique platform that invests in and partners with disruptive leaders whose mission is to align and transform healthcare through what is truly value-based care.